0000914190-21-000214.txt : 20210810
0000914190-21-000214.hdr.sgml : 20210810
20210810182044
ACCESSION NUMBER: 0000914190-21-000214
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210806
FILED AS OF DATE: 20210810
DATE AS OF CHANGE: 20210810
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Furlow Brenda S.
CENTRAL INDEX KEY: 0001443851
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 211161383
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2021-08-06
0000842023
BIO-TECHNE Corp
TECH
0001443851
Furlow Brenda S.
614 MCKINLEY PLACE NE
MINNEAPOLIS
MN
55413
0
1
0
0
SVP - General Counsel
Common Stock
2021-08-08
4
M
0
1374
0
A
7498
D
Common Stock
2021-08-08
4
F
0
677
481.82
D
6821
D
Stock Options (Right to Buy)
108.49
2022-08-07
Common Stock
921
921
D
Stock Options (Right to Buy)
106.59
2023-08-18
Common Stock
3538
3538
D
Stock Options (Right to Buy)
125.05
2024-08-09
Common Stock
9503
9503
D
Stock Options (Right to Buy)
125.05
2024-08-09
Common Stock
12670
12670
D
Restricted Stock Units
2021-08-08
4
M
0
1374
0
D
Common Stock
1374
0
D
Stock Options (Right to Buy)
177.32
2025-08-08
Common Stock
7339
7339
D
Stock Options (Right to Buy)
177.32
2025-08-08
Common Stock
9786
9786
D
Restricted Stock Units
Common Stock
1969
1969
D
Stock Options (Right to Buy)
190.41
2026-08-07
Common Stock
9968
9968
D
Stock Options (Right to Buy)
190.41
2026-08-07
Common Stock
13290
13290
D
Restricted Stock Units
Common Stock
1679
1679
D
Stock Options (Right to Buy)
267.87
2027-08-05
Common Stock
7492
7492
D
Stock Options (Right to Buy)
267.87
2027-08-05
Common Stock
9990
9990
D
Stock Options (Right to Buy)
267.87
2027-08-05
Common Stock
8325
8325
D
Stock Options (Right to Buy)
267.87
2027-08-05
Common Stock
8325.0
8325.0
D
Stock Options (Right to Buy)
372.44
2022-08-31
2028-03-01
Common Stock
10997
10997
D
Restricted Stock Units
2021-08-06
4
A
0
1167
0
A
Common Stock
1167
1167
D
Stock Options (Right to Buy)
481.82
2021-08-06
4
A
0
4560
0
A
2028-08-06
Common Stock
4560
4560
D
Stock Options (Right to Buy)
481.82
2021-08-06
4
A
0
6080
0
A
2028-08-06
Common Stock
6080
6080
D
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
Fully exercisable.
Vested in full on 8/8/2021 upon the certification of achievement of performance goals.
Options to purchase 2,447 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 2,446 shares vest on each of 8/8/2021 and 8/8/2022.
Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 3,323 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 3,322 shares vest on each of 8/7/2022 and 8/7/2023.
Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 2,498 shares vest on each of 8/5/2021 and 8/5/2022 and options to purchase 2,497 shares vest on each of 8/5/2023 and 8/5/2024.
Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 1,520 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
/s/ Andrew Nick as Attorney-in-Fact for Brenda S. Furlow pursuant to Power of Attorney previously filed.
2021-08-10